Insulin is a powerful molecule created by the body that can cause significant harm if used incorrectly but is also life-saving when used correctly
The peptide has been studied extensively across various organ systems, demonstrating cytoprotective effects in the gastrointestinal tract, liver, pancreas, heart, blood vessels, muscle, tendon, ligament, bone, and nervous system
Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
This proposed synergy and the specific doses here are not clinically validated , and neither compound has approved human use
Patients who show evidence of endoscopic recurrence are then offered treatment